A2N Holdings , Abu Dhabi| Bridging Aspirations to New Horizons

A2N Holdings
Empowering Progress, One Venture at a Time.

About Us

At A2N HOLDINGS, our journey is fueled by a passionate drive to create meaningful impact and forge new horizons

Who We Are?

At A2N HOLDINGS, we are a pioneering investment company headquartered in the UAE. Under the visionary guidance of Dr. Ankit Srivastava, we are dedicated to driving innovation and growth across diverse industries. Our team’s expertise and unwavering commitment have positioned us as a force to be reckoned with in the business landscape.

Diversity is our cornerstone. With a well-trained and skilled team, we extend our reach into various fields, from healthcare to technology. Our ethos revolves around seizing opportunities, fostering innovation, and building ventures from the ground up. At A2N HOLDINGS, we don’t just invest; we catalyze transformation.

Our Skills

Innovation 80

Business Development 90

Global Expansion 90

Our Services

At A2N HOLDINGS, we offer a range of services aimed at driving growth, innovation, and value creation. Our expertise spans various domains, and our commitment to excellence sets us apart.

Investment Solutions

We specialize in uncovering and incubating new investment initiatives, helping businesses expand and thrive.

Diverse Ventures

With a focus on healthcare and beyond, we extend our portfolio into various sectors, fostering innovation and growth.

Strategic Partnerships

Our dedication to forming value-based partnerships propels businesses towards success and global recognition.

Global Market Engagement

We navigate the international arena, expanding horizons and embracing opportunities on a global scale.

Business Development

From ground-zero to soaring heights, we craft and nurture companies, steering them to success even amidst challenges.

Innovation Catalyst

We're at the forefront of innovation, identifying untapped potential and leveraging technology to drive growth.

Medisal Pharma

Abu Dhabi, United Arab Emirates

Dubai-based OMS PHARMA is a venture by A2N HOLDINGS that has been striving to establish a number of manufacturing plants to make the region self-sufficient in the field of medicine. The major focus remains the production of goods and services locally to not only ease the access to healthcare but also to generate employment in the region.